Quality assessment of type 1 diabetes mellitus clinical practice guidelines
10.13699/j.cnki.1001-6821.2015.14.030
- VernacularTitle:国内外1型糖尿病临床实践指南质量评价
- Author:
Hang LI
1
;
Xiao-Han XU
;
Suo-Di ZHAI
Author Information
1. 北京大学第三医院药剂科
- Keywords:
type 1 diabetes mellitus;
diabetes;
guidelines;
quality;
appraisal of guidelines for research and evaluation Ⅱ
- From:
The Chinese Journal of Clinical Pharmacology
2015;(14):1455-1458
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the quality of clinical practice guide-lines (CPGs) for type 1 diabetes mellitus(T1DM), so as to provide rec-ommendations for regulating the development of diabetes evidence-based clinical guidelines and updating the existing diabetes clinical guidelines. Methods CNKI, WANFANG, PubMed, EMBase, China guideline clearinghouse(CGC), national guideline clearinghouse (NGC), guide-lines international network ( G-I-N) were searched for CPGs published between January 1st 2009 and July 31st 2014 for type 1 diabetes.Two in-dependent assessors assessed the quality of each CPG using the appraisal of guidelines for research and evaluation Ⅱ ( AGREE Ⅱ) instrument. Results Sixteen guidelines were evaluated in which 15 are in English and the other is in Chinese.The mean scores for each domain were:scope and purpose 72%, stakeholder involvement 53%, rigor of development 51%, clarity of presentation 72%, applicability 53%, editorial independence 49%.Five guidelines ( NICE, BOHTA, CDA, SIGN, NKF ) scored above 50% in each domain.Conclusion The overall quality of CPGs for glycemic control in T1DM is quite well.Greater efforts are needed to improve Chinese T1DM guideline quality, especially in the domain of rigor, stakeholder, applicability and editorial independence.
